-
For Potential CF Therapy ARV-1801, Arrevus Secures Loan
Arrevus received a loan from the North Carolina Biotechnology Center to advance ARV-1801 for the treatment of pulmonary exacerbations in CF patients. Read the full story here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.